rewirebio.iobenchmarks
Evaluation

So 2024 VarSome-vs-CanVIG-UK agreement evaluation

Scoped author-reported evaluation; read protocol and cohort limits before comparing.

Evaluation results

1 evaluation · 2 results. Different protocols are not a single leaderboard.

Protocol: So 2024 VarSome-vs-CanVIG-UK agreement on conflicting BRCA1 missense variants · Dataset: So 2024 BRCA1 conflicting-classification missense cohort

Sorted by Percent agreement (higher is better). The best value in each column is highlighted. Decimals are rounded for display; each value links to the printed value and its source.

Tested configurationPercent agreementCount (concordant classifications)
VarSome vs. CanVIG-UK three-category concordance comparisonEvaluation58.9%265
All 2 result rows with coverage, uncertainty and sources
Filter evaluations

Applied filters: All linked evaluations

Exact evaluated configurations and original reported results
Tested configurationProtocol and datasetFindingEvidence and details
Configuration: VarSome vs. CanVIG-UK three-category concordance comparisonProtocol: So 2024 VarSome-vs-CanVIG-UK agreement on conflicting BRCA1 missense variants
Dataset: So 2024 BRCA1 conflicting-classification missense cohort
58.9% Percent agreement
percent · higher

Uncertainty: 95% CI 52.0 to 66.4

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

So 2024 VarSome-vs-CanVIG-UK agreement evaluation

Not reported

Aggregation: Not reported

Reinterpretation of Conflicting ClinVar BRCA1 Missense Variants Using VarSome and CanVIG-UK Gene-Specific Guidance · Results, Section 3.3, "Comparison of Classification Results Between Varsome and CanVIG-UK": "The overall concordance rate was 58.9% (95% CI: 52.0-66.4%; 265/450) between VarSome and CanVIG-UK (Figure 2)."
Configuration: VarSome vs. CanVIG-UK three-category concordance comparisonProtocol: So 2024 VarSome-vs-CanVIG-UK agreement on conflicting BRCA1 missense variants
Dataset: So 2024 BRCA1 conflicting-classification missense cohort
265 Count (concordant classifications)
count · unknown

Uncertainty: Not applicable: reported at the rate level only; see concordance_rate result

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

So 2024 VarSome-vs-CanVIG-UK agreement evaluation

Not reported

Aggregation: Not reported

Reinterpretation of Conflicting ClinVar BRCA1 Missense Variants Using VarSome and CanVIG-UK Gene-Specific Guidance · Results, Section 3.3, "Comparison of Classification Results Between Varsome and CanVIG-UK": "The overall concordance rate was 58.9% (95% CI: 52.0-66.4%; 265/450) between VarSome and CanVIG-UK (Figure 2)."

Source checking is not independent reproduction. Release 2026-11-21-adc15377fab2.

Research readiness

0 of 4 readiness checks met. These checks assess whether the evidence supports a reproducible investigation; a source-checked score alone does not meet them.

Readiness checks, gaps and artifacts

Release 2026-11-21-adc15377fab2 · Evidence verified: Not verified

Evidence incomplete

Replay metrics

Exact outcomes, predictions, identifiers and evaluator are connected.

Missing or unresolved evidence

  • No verified artifact manifest is linked to this exact record.
  • File checksums match the recorded files: not yet verified
  • Predictions are matched to the right samples: not yet verified
  • Score meaning and direction are confirmed: not yet verified
  • Metrics are recomputed from the saved predictions: not yet verified

Verified: Not verified

Evidence incomplete

Investigate discrepancies

Replay evidence includes annotations and an assessment of dependence. Unknown independence permits descriptive analysis only.

Missing or unresolved evidence

  • No verified artifact manifest is linked to this exact record.
  • File checksums match the recorded files: not yet verified
  • Predictions are matched to the right samples: not yet verified
  • Score meaning and direction are confirmed: not yet verified
  • Metrics are recomputed from the saved predictions: not yet verified
  • Sample annotations are recorded: not yet verified
  • Dependence between samples is assessed: not yet verified

Verified: Not verified

Evidence incomplete

Run locally

A pinned recipe describes the inputs, environment and resource requirements.

Missing or unresolved evidence

  • No verified artifact manifest is linked to this exact record.
  • File checksums match the recorded files: not yet verified
  • Predictions are matched to the right samples: not yet verified
  • Score meaning and direction are confirmed: not yet verified
  • A pinned run recipe exists: not yet verified
  • Compute requirements are estimated: not yet verified

Verified: Not verified

Evidence incomplete

Validate independently

Separate data and exposure records support an independent test.

Missing or unresolved evidence

  • No verified artifact manifest is linked to this exact record.
  • File checksums match the recorded files: not yet verified
  • Predictions are matched to the right samples: not yet verified
  • Score meaning and direction are confirmed: not yet verified
  • Independent validation data exist: not yet verified
  • Overlap with training data is checked: not yet verified

Verified: Not verified

Readiness describes the evidence in this release. Availability on your computer is checked separately when an investigation runs. Existing data exposure can prevent independent validation even when files are available.

Artifacts and reproduction

No verified artifact manifest is connected to this record yet. The gaps above identify what is needed before analysis can begin.

Evaluation procedure

Configuration
VarSome vs. CanVIG-UK three-category concordance comparison
Protocol
So 2024 VarSome-vs-CanVIG-UK agreement on conflicting BRCA1 missense variants
Dataset
So 2024 BRCA1 conflicting-classification missense cohort
origin
Author-reported evaluation
configuration
Not reported
protocol id
uc-clinical-20261005-so-2024-protocol
dataset version
Not reported
split
Not reported
population
So 2024 450-variant BRCA1 conflicting-classification cohort
inputs
Not reported
adaptation
Not reported
metric implementation
Source-defined endpoint; see result source_locator
aggregation
Not reported
budget
Not reported

Metadata review: source checked. Unreported conditions prevent automatic comparisons.

Reproduction

Split
Not reported
Adaptation
Not reported
Scoring implementation
Source-defined endpoint; see result source_locator

No execution recipe has been verified for this exact configuration and evaluation. A benchmark's general instructions may use different inputs, splits or model settings.

Reproducing this published result requires matching its model configuration, data, split and scorer. Source checking or a successful smoke test does not establish score reproduction.

Evidence

Source checking verifies the cited claim or transcription. It does not establish independent reproduction.

Evidence table

Inspect claims, sources and review details

Trace each statement to its source and review. A context-only reference supports the record generally; it does not verify an individual field. Source checking does not reproduce an experiment.

One row per statement and cited source. Multiple citations are not independent evaluations. Shared locators are labelled explicitly.

16 evidence rows matching the loaded filters

Claims, original sources and review scope · Release 2026-11-21-adc15377fab2
Property and statementOriginal source and locationReview and provenance
Comparison: adaptation
Not reported
Context-only references
Reinterpretation of Conflicting ClinVar BRCA1 Missense Variants Using VarSome and CanVIG-UK Gene-Specific Guidance

Original source ↗

Results, Section 3.3, "Comparison of Classification Results Between Varsome and CanVIG-UK"

Version: 2024 published article (Diagnostics (Basel)); CanVIG-UK gene-specific guidance v1.17 / consensus specification v2.17 applied
Retrieved: 2026-10-05T14:02:27Z

missing or unspecified

No individual claim review recorded

author reported

Audit details

Field: attributes.comparison.adaptation

Source artifact SHA-256: 1c38f665dab61743881dcb40302e0e5e0583aa72e106c95a3939a21d6213beda

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

Comparison: aggregation
Not reported
Context-only references
Reinterpretation of Conflicting ClinVar BRCA1 Missense Variants Using VarSome and CanVIG-UK Gene-Specific Guidance

Original source ↗

Results, Section 3.3, "Comparison of Classification Results Between Varsome and CanVIG-UK"

Version: 2024 published article (Diagnostics (Basel)); CanVIG-UK gene-specific guidance v1.17 / consensus specification v2.17 applied
Retrieved: 2026-10-05T14:02:27Z

missing or unspecified

No individual claim review recorded

author reported

Audit details

Field: attributes.comparison.aggregation

Source artifact SHA-256: 1c38f665dab61743881dcb40302e0e5e0583aa72e106c95a3939a21d6213beda

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

Comparison: budget
Not reported
Context-only references
Reinterpretation of Conflicting ClinVar BRCA1 Missense Variants Using VarSome and CanVIG-UK Gene-Specific Guidance

Original source ↗

Results, Section 3.3, "Comparison of Classification Results Between Varsome and CanVIG-UK"

Version: 2024 published article (Diagnostics (Basel)); CanVIG-UK gene-specific guidance v1.17 / consensus specification v2.17 applied
Retrieved: 2026-10-05T14:02:27Z

missing or unspecified

No individual claim review recorded

author reported

Audit details

Field: attributes.comparison.budget

Source artifact SHA-256: 1c38f665dab61743881dcb40302e0e5e0583aa72e106c95a3939a21d6213beda

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

Comparison: dataset version
Not reported
Context-only references
Reinterpretation of Conflicting ClinVar BRCA1 Missense Variants Using VarSome and CanVIG-UK Gene-Specific Guidance

Original source ↗

Results, Section 3.3, "Comparison of Classification Results Between Varsome and CanVIG-UK"

Version: 2024 published article (Diagnostics (Basel)); CanVIG-UK gene-specific guidance v1.17 / consensus specification v2.17 applied
Retrieved: 2026-10-05T14:02:27Z

missing or unspecified

No individual claim review recorded

author reported

Audit details

Field: attributes.comparison.dataset_version

Source artifact SHA-256: 1c38f665dab61743881dcb40302e0e5e0583aa72e106c95a3939a21d6213beda

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

Comparison: inputs
Not reported
Context-only references
Reinterpretation of Conflicting ClinVar BRCA1 Missense Variants Using VarSome and CanVIG-UK Gene-Specific Guidance

Original source ↗

Results, Section 3.3, "Comparison of Classification Results Between Varsome and CanVIG-UK"

Version: 2024 published article (Diagnostics (Basel)); CanVIG-UK gene-specific guidance v1.17 / consensus specification v2.17 applied
Retrieved: 2026-10-05T14:02:27Z

missing or unspecified

No individual claim review recorded

author reported

Audit details

Field: attributes.comparison.inputs

Source artifact SHA-256: 1c38f665dab61743881dcb40302e0e5e0583aa72e106c95a3939a21d6213beda

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

Comparison: metric implementation
Source-defined endpoint; see result source_locator
Context-only references
Reinterpretation of Conflicting ClinVar BRCA1 Missense Variants Using VarSome and CanVIG-UK Gene-Specific Guidance

Original source ↗

Results, Section 3.3, "Comparison of Classification Results Between Varsome and CanVIG-UK"

Version: 2024 published article (Diagnostics (Basel)); CanVIG-UK gene-specific guidance v1.17 / consensus specification v2.17 applied
Retrieved: 2026-10-05T14:02:27Z

not individually reviewed

No individual claim review recorded

author reported

Audit details

Field: attributes.comparison.metric_implementation

Source artifact SHA-256: 1c38f665dab61743881dcb40302e0e5e0583aa72e106c95a3939a21d6213beda

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

Comparison: population
So 2024 450-variant BRCA1 conflicting-classification cohort
Context-only references
Reinterpretation of Conflicting ClinVar BRCA1 Missense Variants Using VarSome and CanVIG-UK Gene-Specific Guidance

Original source ↗

Results, Section 3.3, "Comparison of Classification Results Between Varsome and CanVIG-UK"

Version: 2024 published article (Diagnostics (Basel)); CanVIG-UK gene-specific guidance v1.17 / consensus specification v2.17 applied
Retrieved: 2026-10-05T14:02:27Z

not individually reviewed

No individual claim review recorded

author reported

Audit details

Field: attributes.comparison.population

Source artifact SHA-256: 1c38f665dab61743881dcb40302e0e5e0583aa72e106c95a3939a21d6213beda

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

Comparison: protocol id
uc-clinical-20261005-so-2024-protocol
Context-only references
Reinterpretation of Conflicting ClinVar BRCA1 Missense Variants Using VarSome and CanVIG-UK Gene-Specific Guidance

Original source ↗

Results, Section 3.3, "Comparison of Classification Results Between Varsome and CanVIG-UK"

Version: 2024 published article (Diagnostics (Basel)); CanVIG-UK gene-specific guidance v1.17 / consensus specification v2.17 applied
Retrieved: 2026-10-05T14:02:27Z

not individually reviewed

No individual claim review recorded

author reported

Audit details

Field: attributes.comparison.protocol_id

Source artifact SHA-256: 1c38f665dab61743881dcb40302e0e5e0583aa72e106c95a3939a21d6213beda

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

Comparison: split
Not reported
Context-only references
Reinterpretation of Conflicting ClinVar BRCA1 Missense Variants Using VarSome and CanVIG-UK Gene-Specific Guidance

Original source ↗

Results, Section 3.3, "Comparison of Classification Results Between Varsome and CanVIG-UK"

Version: 2024 published article (Diagnostics (Basel)); CanVIG-UK gene-specific guidance v1.17 / consensus specification v2.17 applied
Retrieved: 2026-10-05T14:02:27Z

missing or unspecified

No individual claim review recorded

author reported

Audit details

Field: attributes.comparison.split

Source artifact SHA-256: 1c38f665dab61743881dcb40302e0e5e0583aa72e106c95a3939a21d6213beda

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

Origin
author_reported
Context-only references
Reinterpretation of Conflicting ClinVar BRCA1 Missense Variants Using VarSome and CanVIG-UK Gene-Specific Guidance

Original source ↗

Results, Section 3.3, "Comparison of Classification Results Between Varsome and CanVIG-UK"

Version: 2024 published article (Diagnostics (Basel)); CanVIG-UK gene-specific guidance v1.17 / consensus specification v2.17 applied
Retrieved: 2026-10-05T14:02:27Z

not individually reviewed

No individual claim review recorded

author reported

Audit details

Field: attributes.origin

Source artifact SHA-256: 1c38f665dab61743881dcb40302e0e5e0583aa72e106c95a3939a21d6213beda

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

How to read the evidence

Sources and history

Release 2026-11-21-adc15377fab2 · Record review: source checked

1 source record and release historyDownload this release (gzip)
Technical metadata and extraction receipts

Stable ID: uc-clinical-20261005-so-2024-evaluation

areas
dna-genomes
contexts
clinical_research
origin
author_reported
source locator
Results, Section 3.3, "Comparison of Classification Results Between Varsome and CanVIG-UK"
review
method: automated-source-review; reviewer: claude-sonnet; date: 2026-10-05; note: Transcription from inspected primary source. No execution, independent replication or human scientific review.; source id: uc-clinical-20261005-source-so-2024; reviewer note: role: clinical coverage worker (research-evidence intake)
comparison
protocol id: uc-clinical-20261005-so-2024-protocol; dataset version: Not reported; split: Not reported; population: So 2024 450-variant BRCA1 conflicting-classification cohort; inputs: Not reported; adaptation: Not reported; metric implementation: Source-defined endpoint; see result source_locator; aggregation: Not reported; budget: Not reported
Related records

Suggest a correction